Hatch-Waxman Allowed Prevacid IP Suit, Takeda Tells 3rd Circ.
Takeda urged the Third Circuit not to revive allegations from Zydus that it used sham patent litigation to delay generic competition for its heartburn medication Prevacid, arguing that the claims would...To view the full article, register now.
Already a subscriber? Click here to view full article